96 related articles for article (PubMed ID: 8109851)
1. Effects of cyclosporine-A and cyclosporine-G on ADP-stimulated aggregation of human platelets.
Markell MS; Fernandez J; Naik UP; Ehrlich Y; Kornecki E
Ann N Y Acad Sci; 1993 Nov; 696():404-7. PubMed ID: 8109851
[No Abstract] [Full Text] [Related]
2. The effects of cyclosporine on human platelet aggregation and thromboxane release.
Jorkasky DK; Fisher CA; Stahl RF; Addonizio VP; Glickman JD
Transplant Proc; 1989 Feb; 21(1 Pt 1):948-9. PubMed ID: 2705264
[No Abstract] [Full Text] [Related]
3. Enhancement by cyclosporine A and tacrolimus of serotonin-induced formation of small platelet aggregation.
Suehiro A; Sawada A; Hasegawa Y; Takatsuka H; Higasa S; Kakishita E
Bone Marrow Transplant; 2002 Jan; 29(2):107-11. PubMed ID: 11850703
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981).
Fox SC; Judge HM; Allen BR; Heptinstall S
Platelets; 2002 Jun; 13(4):213-8. PubMed ID: 12189022
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of human platelet aggregation and secretion induced by rapamycin.
Babinska A; Markell MS; Salifu MO; Akoad M; Ehrlich YH; Kornecki E
Nephrol Dial Transplant; 1998 Dec; 13(12):3153-9. PubMed ID: 9870481
[TBL] [Abstract][Full Text] [Related]
6. FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function.
Pelekanou V; Trezise AE; Moore AL; Kay JE
Transplant Proc; 1991 Dec; 23(6):3200-1. PubMed ID: 1721408
[No Abstract] [Full Text] [Related]
7. Effect of cyclosporine on platelet aggregation in renal transplant recipients.
Scott JP; Nunez D; Reardon D; Luddington R; Folawski J; Evans DB; Higenbottam TW; Calne R
Transplant Proc; 1987 Oct; 19(5):4008. PubMed ID: 3313986
[No Abstract] [Full Text] [Related]
8. Cyclosporine A enhances agonist-induced aggregation of human platelets by stimulating protein phosphorylation.
Naik UP; Markell M; Ehrlich YH; Kornecki E
Cell Mol Biol Res; 1993; 39(3):257-64. PubMed ID: 8293040
[TBL] [Abstract][Full Text] [Related]
9. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
Fernandes JB; Naik UP; Markell MS; Kornecki E
Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
[TBL] [Abstract][Full Text] [Related]
10. The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels.
Jacobs TW; Katz IA; Joffe II; Stein B; Takizawa M; Epstein S
Transplant Proc; 1991 Dec; 23(6):3188-9. PubMed ID: 1721403
[No Abstract] [Full Text] [Related]
11. The effects of cyclosporine A, cyclosporine G, and FK 506 upon prostaglandin production in renal mesangial cells in culture.
McCauley J; Studer R; Craven P; Murray S
Transplant Proc; 1991 Dec; 23(6):3141-2. PubMed ID: 1721384
[No Abstract] [Full Text] [Related]
12. Effects of azathioprine and mizoribine on aggregation of normal and uremic platelets.
Malyszko JS; Malyszko J; Pawlak K; Mysliwiec M; Takada Y; Takada A
Transplant Proc; 1996 Dec; 28(6):3488-9. PubMed ID: 8962356
[No Abstract] [Full Text] [Related]
13. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
Masri MA
Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
[No Abstract] [Full Text] [Related]
14. Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
Malyszko J; Pawlak D; Pawlak K; Malyszko JS; Buczko W; Azzudin A; Mysliwiec M
Transplant Proc; 1996 Jun; 28(3):1954-7. PubMed ID: 8658959
[No Abstract] [Full Text] [Related]
15. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270
[TBL] [Abstract][Full Text] [Related]
16. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
17. Evidence that cyclosporine-incubated platelets retain function and release cyclosporine.
Sharpe RJ; Schweizer RT; Moore RE; Calaluce RD; Johnson RL; Michalski PA; Bow LM
Transplantation; 1985 Jul; 40(1):102-4. PubMed ID: 4012843
[No Abstract] [Full Text] [Related]
18. Cyclosporine impairs the ability of human platelets to mediate vasodilation.
Oskarsson HJ; Hofmeyer TG; Olivari MT
Hypertension; 1997 Jun; 29(6):1314-21. PubMed ID: 9180635
[TBL] [Abstract][Full Text] [Related]
19. New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation.
Hiestand PC; Gräber M; Hurtenbach U; Herrmann P; Cammisuli S; Richardson BP; Eberle MK; Donatsch P; Ryffel B; Borel JF
Transplant Proc; 1993 Feb; 25(1 Pt 1):691-2. PubMed ID: 8438439
[No Abstract] [Full Text] [Related]
20. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
Harrison MJ; Brossmer R
Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
